About The
About The
Table of Contents
1 Brief Description 3
3 Quick Facts 4
4 Scales 5
5 Norm Groups 6
6 Report Options 6
Copyright © 2001, 2006, 2010 NCS Pearson, Inc. All rights reserved.
Pearson is a trademark in the U.S. and/or other countries of Pearson Education, Inc., or its
affiliates(s). MBMD and Millon are registered trademarks of DICANDRIEN, Inc.
2
About the MBMD
1 Brief Description
The Millon® Behavioral Medicine Diagnostic (MBMD) test is a powerful assessment that
offers a contemporary view of the psychosocial assets and liabilities that may support
or interfere with a patient’s course of medical treatment.
The MBMD assessment provides information that may guide physicians, psychologists,
nurses, and other professionals toward a broader understanding of a patient’s bio-
psycho-social health. The test was designed to help increase the probability of positive
healthcare treatment outcomes, which may reduce medical utilization and the overall
cost of care.
New updates include norms for the bariatric and pain populations, increasing the
overall utility of the MBMD test among patients being assessed for weight-loss surgery
and in pain settings.
Table of
Contents
3
2 About the Authors continued
testing the effects of cognitive behavioral stress management (CBSM) interventions on
psychological adjustment, immune system functioning, and health outcomes in HIV-
infected men and women, women with Human Papilloma Virus-associated cervical
dysplasia, women with breast cancer, men with prostate cancer, and men and women
with chronic fatigue syndrome. He is a Fellow of the Society of Behavioral Medicine, and
is Associate Editor for the International Journal of Behavioral Medicine and Psychology
and Health. He has published over 400 journal articles, abstracts, chapters and books in
the area of health psychology.
3 Quick Facts
Publisher: Pearson
Table of
Contents
4
4 Scales
Response Patterns
Scale V Validity
Scale X Disclosure
Scale Y Desirability
Scale Z Debasement
Psychiatric Indications
Scale AA Anxiety-Tension
Scale BB Depression
Scale CC Cognitive Dysfunction
Scale DD Emotional Lability
Scale EE Guardedness
Coping Styles
Scale 1 Introversive
Scale 2A Inhibited
Scale 2B Dejected
Scale 3 Cooperative
Scale 4 Sociable
Scale 5 Confident
Scale 6A Nonconforming
Scale 6B Forceful
Scale 7 Respectful
Scale 8A Oppositional
Scale 8B Denigrated
Stress Moderators
Scale A Illness Apprehension
Scale B Functional Deficits
Scale C Pain Sensitivity
Scale D Social Isolation
Scale E Future Pessimism
Scale F Spiritual Absence
Treatment Prognostics
Scale G Interventional Fragility
Scale H Medication Abuse
Scale I Information Discomfort
Scale J Utilization Excess
Scale K Problematic Compliance
Table of
Contents
5
4 Scales continued
Management Guides
Scale L Adjustment Difficulties
Scale M Psych Referral
5 Norm Groups
The normative population of the MBMD test consists of three distinct groups. The first
includes more than 700 patients with a wide variety of medical conditions, including
cancer, diabetes, HIV/AIDS, chronic pain, heart problems, neurological disorders,
gastrointestinal problems, gynecological problems, injuries, and organ transplants.
The second normative sample is composed of 711 patients from around the U.S. who
were undergoing pre-surgical psychological evaluation for bariatric surgery. The third
normative sample is comprised of 1,200 patients from the United States being treated
for issues involving chronic pain.
6 Report Options
Administrators have the option to print profile and interpretive reports based on general
medical, bariatric, or pain-specific populations.
Profile Report
This report provides a profile of the prevalence scores for all the content scales, plus a
rating of the likelihood of a problem indicated by the individual’s Response Patterns and
Negative Health Habits scores. These easy-to-read graphics can help give clinicians a
quick picture of a patient’s strengths and weaknesses. The profile report also includes a
Noteworthy Responses section that alerts the clinician to potential problem areas that
need follow-up.
Bariatric Report
Table of
Contents
6
6 Report Options continued
The interpretive report narrative provides a detailed analysis of the patient’s potential
strengths and weaknesses. Health and clinical psychologists can use this information
to help other medical professionals develop comprehensive and successful treatment
plans for patients.
This report provides an interpretation for each of the five domains (Psychiatric
Indications, Coping Styles, Stress Moderators, Treatment Prognostics, and Management
Guides), plus a Noteworthy Responses section that alerts the clinician to potential
problem areas that need follow-up. The Management Guide serves as a summary,
helping to identify problems that may call for psychological referral and/or medication.
Depending on the norm group selection, the MBMD Interpretive Report includes
specifically tailored considerations for clinicians to help serve as guides in making
prudent and tentative judgments.
If an administration is unscorable, you must fill in the appropriate responses or raw scores
before you can score the instrument.
Table of
Contents
7
7 Scoring and Reporting Rules continued
This report is invalid if the following condition is true:
Unless you have modified your default system settings, you will always be asked whether
or not you want to print an invalid report. An on-screen message will briefly describe the
invalidity condition and the data you will receive if you print the report. For example,
an invalid report might include a printout of raw and transformed scores, but the scores
would not be plotted and no interpretation would be attempted.
Table of
Contents
8
8 Data Export Labels continued
Table of
Contents
9
8 Data Export Labels continued
Table of
Contents
10
8 Data Export Labels continued
Table of
Contents
11
8 Data Export Labels continued
Table of
Contents
12
9 FAQs (Frequently Asked Questions)
What is the MBMD test designed to do?
Medical researchers and healthcare practitioners understand that psychological and
personality factors are major contributors to positive health outcomes. The MBMD test
can help identify the main psychosocial factors that can contribute to the recovery
from, relapse of, or progression of physical disease. Addressing these factors can help
medical professionals better treat their patients. The results may be improved treatment
success and rehabilitation/recovery from disease, as well as reduced medical utilization
and contained healthcare costs.
It is not appropriate to use the MBMD test with adolescents. The age range for the
MBMD test is 18 to 89 years old.
In 2006, bariatric-specific norms were released for the MBMD test. Using data from
711 prescreened bariatric surgery patients collected from six geographically diverse
settings, a bariatric reporting option was developed to represent this unique medical
population. Approximately 82% of this sample were female, 65% were Caucasian, 54%
were married, and 89% had at least a high school diploma.
Pain patient-specific norms were released for the MBMD in 2010. All 1,200 pain patients,
pulled from diverse settings across the U.S., were given the MBMD. This data helped
to develop two reports tailored to help assess individuals in two primary pain patient
settings, Presurgical and Nonsurgical. Approximately 54% of this sample were female,
69% were Caucasian, 62% were married, and 46% had at least a high school diploma.
There are several differences between the norm groups. Bariatric and pain patients
tend to be more concerned about illness, less able to do things, and in more pain than
the general medical population. Differences such as these indicate that the average
bariatric or pain patient is not only physically different from the general medical
population but psychologically different as well, justifying the effort to bring more
specific norm groups to MBMD users.
Table of
Contents
13
9 FAQs (Frequently Asked Questions) continued
How is the MBMD test different from the MBHI test?
Like the MBHI assessment, the MBMD test provides information about a patient’s
coping style. However, it also provides new scales (stress moderators, treatment
prognostics, psychiatric indications, and management guides) and negative health
habits and response patterns. The MBMD test also includes a larger range of patient
populations and clinical settings. The MBMD interpretive report includes a one-page
Healthcare Provider Summary, which outlines assessment findings and treatment
recommendations. Our customer research has shown that medical professionals are
most interested in obtaining this type of patient information.
How does the MBMD test differ from other medically based psychosocial tests?
Like other personality tests, the MBMD test provides information about a patient’s
coping style. However, it also provides new scales (stress moderators, treatment
prognostics, and psychiatric indications), and negative health habits. The interpretive
report takes each patient’s individual style of coping into account in mediating the
patient’s psychiatric symptoms, personal assets, external resources, and healthcare
utilization. Thus, the interpretive report captures the process of synthesis that a seasoned
clinician would use in integrating information from multiple test instruments. All of this
can be achieved with high external validity and with minimal patient burden given that
each MBMD test administration requires 20-25 minutes for the patient to complete.
Using a smaller sample (N=41), test-retest reliability estimates were also obtained:
Psychiatric Indications (rTT=.79 to .88), Coping Styles (rTT=.71 to .90), Stress Moderators
(rTT=.78 to .92), Treatment Prognostics (rTT=.72 to .88), and Management Guides (rTT=.78
to .81). The median test-retest coefficient for all scales is rTT=.83.
Internal consistency and test-retest analyses were also conducted for the bariatric
patient sample, resulting in the following reliability estimates: Psychiatric Indicators
(rTT = .70 to .85), Coping Styles (rTT = .56 to .80), Stress Moderators (rTT = .77 to .89),
Treatment Prognostics (rTT = .22 to .71), and Management Guides (rTT = .64 to .69).
The median internal consistency coefficient for all scales is rTT = .70.
Table of
Contents
14
9 FAQs (Frequently Asked Questions) continued
What is the validity of the MBMD test?
Several approaches were used to validate the scales included on the MBMD. First,
an item-sorting procedure was used that required several medical professionals to
identify which scale(s) each item appeared to be logically associated with. Only
items that were sorted correctly by the majority of the raters were retained on the test
for further analysis.
Second, after the MBMD scales had been refined based on internal consistency
considerations, scale scores were correlated with a variety of other measures that
assessed similar content domains. For example, the MBMD Depression scale correlated
at .87 with the Beck Depression Inventory and .58 with the Brief Symptom Inventory
Depression scale.
Third, medical professionals who were familiar with approximately 100 patients rated
each patient on a number of attitudes and behaviors that are important to treatment
outcomes (e.g., compliance, medication problems, utilization problems). A number
of significant relationships were found between the MBMD scales and the medical
staff ratings. For example, the Pain Sensitivity scale correlated .62 with a rating of
Pain Experiences. The Adjustment Difficulties scale correlated .61 with a rating of
Utilization Problems.
Table of
Contents
15